Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-029675
Filing Date
2024-06-24
Accepted
2024-06-24 18:38:32
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1719268705.html 4  
1 FORM 4 wk-form4_1719268705.xml 4 8461
  Complete submission text file 0001628280-24-029675.txt   9898
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address
Lecault Veronique (Reporting) CIK: 0001834418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 241065780